To explore whether this process contributes to neuropathology in carriers of heterozygous intragenic NRXN1 deletions, Flaherty et al. [45] established iPSCs from four carriers with major psychiatric disorders, three with early onset, and three healthy controls. Here, NRXN1 is linked to psychiatric disorder.